NCT06566872 Collecting Recorded Videos of Colonoscopy and Gastroscopy Tests for the Evaluation of the (ME-APDS).
| NCT ID | NCT06566872 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Magentiq Eye LTD |
| Condition | Colon Polyp |
| Study Type | OBSERVATIONAL |
| Enrollment | 700 participants |
| Start Date | 2022-05-16 |
| Primary Completion | 2025-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 700 participants in total. It began in 2022-05-16 with a primary completion date of 2025-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study shall mainly help to better evaluate the performance the ME-APDS device and secondly it may help the development of additional future versions of the ME-APDS. Primary endpoints * Clear video of the colon or the stomach or the esophagus achieved during the test. * Acceptable colon or gastro test performance according to the standards, criteria, and regulations of the medical center of the trial. Secondary endpoints • A recorded video of at least 80% of the actual test duration.
Eligibility Criteria
Inclusion Criteria: Subjects must meet all the - criteria related to regular colonoscopy and/or gastroscopy according to the standard of care at the Gastroenterolgy Department of the selected center, \_In addition the following - criteria have to be met to be eligible for the study: 1. Able to read, understand and provide written Informed Consent; 2. Females or males - older than 18 years old Exclusion Criteria: Any of the following colonoscopy/gastroscopy related exclusion criteria will exclude the subject from the study: * Bleeding disorder or unacceptable risk of bleeding * Terminal illness or life threatening malignancy
Contact & Investigator
Haim Shirin, Prof.
PRINCIPAL INVESTIGATOR
Gastroenterology Department of Shamir Medical Center, Israel
Frequently Asked Questions
Who can join the NCT06566872 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Colon Polyp. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06566872 currently recruiting?
Yes, NCT06566872 is actively recruiting participants. Contact the research team at dror@magentiq.com for enrollment information.
Where is the NCT06566872 trial being conducted?
This trial is being conducted at Be’er Ya‘aqov, Israel.
Who is sponsoring the NCT06566872 clinical trial?
NCT06566872 is sponsored by Magentiq Eye LTD. The principal investigator is Haim Shirin, Prof. at Gastroenterology Department of Shamir Medical Center, Israel. The trial plans to enroll 700 participants.